Analysts Set Agilon Health, Inc. (NYSE:AGL) PT at $64.00

Agilon Health, Inc. (NYSE:AGL) has received a consensus rating of “Hold” from the fourteen brokerages that are presently covering the stock, MarketBeat.com reports. Three analysts have rated the stock with a sell recommendation, six have issued a hold recommendation and five have given a buy recommendation to the company. The average twelve-month target price among analysts that have issued a report on the stock in the last year is $66.50.

Several research firms have weighed in on AGL. Wall Street Zen upgraded shares of Agilon Health from a “sell” rating to a “hold” rating in a report on Saturday, May 9th. TD Cowen reaffirmed a “hold” rating and issued a $55.00 price target (up from $17.00) on shares of Agilon Health in a report on Monday, May 11th. Weiss Ratings lowered shares of Agilon Health from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Wednesday, May 27th. JPMorgan Chase & Co. lowered shares of Agilon Health from a “neutral” rating to an “underweight” rating and set a $21.00 price target on the stock. in a research report on Monday, May 4th. Finally, Deutsche Bank Aktiengesellschaft raised shares of Agilon Health from a “hold” rating to a “buy” rating and raised their price objective for the stock from $33.00 to $49.00 in a research note on Thursday, May 7th.

Agilon Health Stock Performance

Shares of AGL stock opened at $97.84 on Thursday. The company has a current ratio of 1.04, a quick ratio of 1.04 and a debt-to-equity ratio of 0.08. The stock has a 50 day simple moving average of $104.97 and a 200-day simple moving average of $50.89. The company has a market cap of $1.63 billion, a price-to-earnings ratio of -4.54 and a beta of 2.98. Agilon Health has a 12-month low of $7.48 and a 12-month high of $133.04.

Agilon Health (NYSE:AGL) last issued its earnings results on Wednesday, May 6th. The company reported $1.80 EPS for the quarter, topping the consensus estimate of $1.04 by $0.76. The company had revenue of $1.42 billion for the quarter, compared to analyst estimates of $1.38 billion. Agilon Health had a negative net margin of 6.09% and a negative return on equity of 146.03%. On average, equities analysts forecast that Agilon Health will post -3.5 EPS for the current year.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the business. LPL Financial LLC raised its holdings in shares of Agilon Health by 213.4% in the 4th quarter. LPL Financial LLC now owns 44,055 shares of the company’s stock worth $30,000 after purchasing an additional 30,000 shares during the period. Krilogy Financial LLC purchased a new stake in shares of Agilon Health during the 4th quarter worth about $34,000. CIBC Bancorp USA Inc. acquired a new stake in Agilon Health during the 3rd quarter worth approximately $34,000. Merit Financial Group LLC purchased a new position in Agilon Health in the fourth quarter valued at approximately $35,000. Finally, Focus Partners Advisor Solutions LLC purchased a new position in Agilon Health in the fourth quarter valued at approximately $53,000.

About Agilon Health

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.